▲ Peaking
Business
Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approaches
Adicet Bio reports positive safety and efficacy data for its CAR-T therapy Prula-cel, signaling a potential new era in the treatment of systemic lupus erythematosus.